VentriPoint Diagnostics (FRA:5V7) Cyclically Adjusted PB Ratio: (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5V7 VentriPoint Diagnostics Ltd FRA:5V7
13 GF Score
Price €0.06
! 4 Warning Signs
View Full Analysis

What is VentriPoint Diagnostics Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


VentriPoint Diagnostics  (FRA:5V7) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


VentriPoint Diagnostics Cyclically Adjusted PB Ratio Related Terms


VentriPoint Diagnostics Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for VentriPoint Diagnostics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VentriPoint Diagnostics Cyclically Adjusted PB Ratio Chart

VentriPoint Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

VentriPoint Diagnostics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:5V7 vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, VentriPoint Diagnostics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VentriPoint Diagnostics Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's Cyclically Adjusted PB Ratio falls into.


FRA:5V7
13GF Score
VentriPoint Diagnostics Ltd FRA:5V7
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VentriPoint Diagnostics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

VentriPoint Diagnostics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 is calculated as:

For example, VentriPoint Diagnostics's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book=Book Value per Share/CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.015/130.3661*130.3661
=-0.015

Current CPI (Dec. 2025) = 130.3661.

VentriPoint Diagnostics Quarterly Data

Book Value per Share CPI Adj_Book
201603 -0.017 101.054 -0.022
201606 -0.036 102.002 -0.046
201609 -0.048 101.765 -0.061
201612 -0.050 101.449 -0.064
201703 -0.049 102.634 -0.062
201706 -0.010 103.029 -0.013
201709 -0.002 103.345 -0.003
201712 -0.021 103.345 -0.026
201803 -0.014 105.004 -0.017
201806 -0.014 105.557 -0.017
201809 -0.002 105.636 -0.002
201812 -0.011 105.399 -0.014
201903 -0.017 106.979 -0.021
201906 -0.024 107.690 -0.029
201909 -0.027 107.611 -0.033
201912 -0.024 107.769 -0.029
202003 -0.026 107.927 -0.031
202006 -0.029 108.401 -0.035
202009 -0.021 108.164 -0.025
202012 -0.017 108.559 -0.020
202103 0.003 110.298 0.004
202106 0.011 111.720 0.013
202109 0.009 112.905 0.010
202112 0.037 113.774 0.042
202203 0.035 117.646 0.039
202206 0.030 120.806 0.032
202209 0.026 120.648 0.028
202212 0.020 120.964 0.022
202303 0.015 122.702 0.016
202306 0.011 124.203 0.012
202309 0.006 125.230 0.006
202312 0.001 125.072 0.001
202403 -0.004 126.258 -0.004
202406 -0.009 127.522 -0.009
202409 -0.010 127.285 -0.010
202412 -0.012 127.364 -0.012
202503 -0.014 129.181 -0.014
202506 -0.015 129.892 -0.015
202509 -0.017 130.287 -0.017
202512 -0.015 130.366 -0.015

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


VentriPoint Diagnostics Business Description

Other Exchanges VPTDF:USAVPT:Canada
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
13GF Score

Get the complete analysis for FRA:5V7

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price